Mead Johnson Nutrition Company (NYSE:MJN) has received a short term rating of hold from experts at Zacks with a rank of 3. The stock has been rated an average of 2.64 by 11 Brokerage Firm. 3 Wall Street Firms have rated the stock as a strong buys. 6 Brokerage Firms have advised hold. A sell rating was given by 2 analyst. Mead Johnson Nutrition Company (NYSE:MJN) : On Tuesday heightened volatility was witnessed in Mead Johnson Nutrition Company (NYSE:MJN) which led to swings in the share price. The stock opened for trading at $82.29 and hit $83.99 on the upside , eventually ending the session at $83.83, with a gain of 1.48% or 1.22 points. The heightened volatility saw the trading volume jump to 1,463,495 shares. The 52-week high of the share price is $104.34 and the company has a market cap of $15,630 million. The 52-week low of the share price is at $65.53 .
Mead Johnson Nutrition Company (NYSE:MJN): The mean estimate for the short term price target for Mead Johnson Nutrition Company (NYSE:MJN) stands at $76.17 according to 6 Analysts. The higher price target estimate for the stock has been calculated at $89 while the lower price target estimate is at $70.
Many analysts have stated their opinion on the company shares. Credit Suisse upgrades its rating on Mead Johnson Nutrition Company (NYSE:MJN). The global brokerage major raises the current price target from $76 per share to $100 per share. Analysts at the Credit Suisse have a current rating of Outperform on the shares. The shares were previously rated Neutral. The rating by the firm was issued on March 16, 2016.
The company shares have dropped 17.83% in the past 52 Weeks. On April 6, 2015 The shares registered one year high of $104.34 and one year low was seen on January 28, 2016 at $65.53. The 50-day moving average is $75.76 and the 200 day moving average is recorded at $76.13. S&P 500 has rallied 1.49% during the last 52-weeks. Investors should note that the Company has disclosed insider buying and selling activities to the Securities Exchange, Cup Michel Martinus Gerardus, CFO of Mead Johnson Nutrition Co, executed a transaction worth $306,000 on December 14, 2015. A total of 4,000 shares were purchased at an average price of $76.5. The Insider information was divulged by the Securities and Exchange Commission in a Form 4 filing. The information is based on open market trades at the market prices.Option exercises are not covered.
Mead Johnson Nutrition Company (Mead Johnson) is a global pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, childrens nutrition and other nutritional products. Its product portfolio includes routine and specialty infant formulas, childrens milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders. The Company operates through three segments: Asia, Latin America and North America/Europe. The Companys Enfa family of brands, including Enfamil infant formula, is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants, children and expectant and nursing mothers. The Company markets its portfolio of more than 70 products to mothers, healthcare professionals and retailers in more than 50 countries in Asia, North America, Latin America and Europe.